|
Federal
Register Notices > Notices
of Application - 2001 > Mallinckrodt,
Inc.
[Federal Register: May 30, 2001 (Volume 66, Number
104)]
[Notices]
[Page 29344]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30my01-86]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of
Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this
is notice that on December 27, 2000, Mallinckrodt, Inc., Mallinckrodt
& Second Streets, St. Louis, Missouri 63147, made application by
renewal to the Drug Enforcement Administration (DEA) for registration as a
bulk manufacturer of the basic classes of controlled substances listed
below:
| Drug |
Schedule |
| Tetrahydrocannabinols (7370) |
I |
| Dihydromorphine (9145) |
I |
| Amphetamine (1100) |
II |
| Methylphenidate (1724) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Diprenorphine (9058) |
II |
| Etorphine Hydrochloride (9059) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Diphenoxylate (9170) |
II |
| Hydrocodone (9193) |
II |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone-intermediate (9254) |
II |
| Dextropopoxyphene, bulk
(non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Opium extracts (9610) |
II |
| Opium fluid extract (9620) |
II |
| Opium tincture (9630) |
II |
| Opium powdered (9639) |
II |
| Opium granulated (9640) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The firm plans to manufacture the controlled
substances for distribution as bulk products to its customers.
Any other such applicant and any person who is
presently registered with DEA to manufacture such substances may file
comments or objections to the issuance of the proposed registration.
Any such comments or objections may be addressed, in
quintuplicate, to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, United States Department of
Justice, Washington, DC 20537, Attention: DEA Federal Register
Representative (CCR), and must be filed no later than July 30, 2001.
Dated: May 14, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 01-13446 Filed 5-29-01; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
